These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1683150)

  • 81. Treatment of non-steroidal anti-inflammatory drug induced enteropathy.
    Bjarnason I; Hopkinson N; Zanelli G; Prouse P; Smethurst P; Gumpel JM; Levi AJ
    Gut; 1990 Jul; 31(7):777-80. PubMed ID: 1973396
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Non-steroidal drug-induced peptic ulceration can we really protect the stomach?
    Sturrock RD
    Br J Rheumatol; 1992 Jul; 31(7):435-6. PubMed ID: 1628163
    [No Abstract]   [Full Text] [Related]  

  • 83. Temporal patterns of response to D-penicillamine, hydroxychloroquine, and placebo in juvenile rheumatoid arthritis patients.
    van Kerckhove C; Giannini EH; Lovell DJ
    Arthritis Rheum; 1988 Oct; 31(10):1252-8. PubMed ID: 3178907
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The action of myocrisin on membrane bound sulphhydryl groups.
    McCrae F; Reglinski J; Smith WE; Brzeski M; Sturrock RD
    Clin Chim Acta; 1990 Dec; 195(1-2):41-5. PubMed ID: 1982710
    [No Abstract]   [Full Text] [Related]  

  • 85. Nonsteroidal anti-inflammatory drugs and peptic ulcers: mechanisms, risk factors and treatment.
    Meryn S
    Clin Exp Rheumatol; 1994; 12(2):119-21. PubMed ID: 8039277
    [No Abstract]   [Full Text] [Related]  

  • 86. Long term outcome of treatment with sulphasalazine in rheumatoid arthritis.
    Situnayake RD; McConkey B
    Drugs; 1986; 32 Suppl 1():71-2. PubMed ID: 2877857
    [No Abstract]   [Full Text] [Related]  

  • 87. Rheumatoid arthritis: can the long-term outcome be altered?
    Gabriel SE; Luthra HS
    Mayo Clin Proc; 1988 Jan; 63(1):58-68. PubMed ID: 3275843
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The gold plated stomach?
    Taha AS; Sturrock RD
    Ann Rheum Dis; 1993 Feb; 52(2):89-90. PubMed ID: 8447702
    [No Abstract]   [Full Text] [Related]  

  • 89. Improving the response to gold or D-penicillamine by addition of sulphasalazine. A pilot study in 25 patients with rheumatoid arthritis.
    Dawes PT; Sheeran TP; Fowler PD; Shadforth MF
    Clin Exp Rheumatol; 1987; 5(2):151-3. PubMed ID: 2886241
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Letter: Peptic ulceration and D-penicillamine.
    Lyle WH
    Lancet; 1974 Aug; 2(7875):285. PubMed ID: 4135704
    [No Abstract]   [Full Text] [Related]  

  • 91. [Acute renal failure induced by non-steroidal antiinflammatory drugs and antirheumatics (gold and D-penicillamine].
    Shiigai T
    Nihon Rinsho; 1991 Jun; 49(6):1328-31. PubMed ID: 1886219
    [No Abstract]   [Full Text] [Related]  

  • 92. The in vivo effect of nonsteroidal anti-inflammatory drugs, gold sodium thiomalate and methotrexate on neutrophil superoxide radical generation.
    Al Balla S; Johnston C; Davis P
    Clin Exp Rheumatol; 1990; 8(1):41-5. PubMed ID: 2161306
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Risk factors for gastrointestinal complications of nonsteroidal antiinflammatory drugs.
    Florent C; Le Loët X; Bardin T
    Rev Rhum Engl Ed; 1996 Feb; 63(2):125-30. PubMed ID: 8689283
    [No Abstract]   [Full Text] [Related]  

  • 94. Pharmacological studies of antigen-induced arthritis in BALB/c mice. II. The effects of second-line antirheumatic drugs and cytotoxic agents on the histopathological changes.
    Hunneyball IM; Crossley MJ; Spowage M
    Agents Actions; 1986 Jun; 18(3-4):394-400. PubMed ID: 2875633
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Drug treatment of progressive rheumatoid arthritis.
    Champion GD; Richter MB
    Ann Acad Med Singap; 1991 Jan; 20(1):127-32. PubMed ID: 2029152
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Sulfasalazine-induced DRESS syndrome associated with Epstein Barr virus reactivation].
    Zaïem A; Aouinti I; Lakhoua G; Sahnoun R; Daghfous R; Lakhal M; El Aïdli S
    Therapie; 2013; 68(5):321-3. PubMed ID: 24225043
    [No Abstract]   [Full Text] [Related]  

  • 97. Optimizing the assessment of disease activity during treatment with anti-rheumatoid drugs.
    Astbury C; Platt R; Dixon JS; Le Gallez P; Hill J; Bird HA
    Br J Rheumatol; 1993 Jun; 32(6):467-73. PubMed ID: 8099519
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Variations among rheumatologists in prescribing and monitoring of disease modifying antirheumatoid drugs.
    Kay EA; Pullar T
    Br J Rheumatol; 1992 Jul; 31(7):477-83. PubMed ID: 1352723
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Lack of interaction between sulphasalazine and cimetidine in patients with rheumatoid arthritis.
    Pirmohamed M; Coleman MD; Galvani D; Bucknall RC; Breckenridge AM; Park BK
    Br J Rheumatol; 1993 Mar; 32(3):222-6. PubMed ID: 8095423
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Computer search for molecular mechanisms of ulcerogenic action of nonsteroidal antiinflammatory drugs].
    Ivanov SM; Lagunin AA; Zakharov AV; Filimonov DA; Poroĭkov VV
    Biomed Khim; 2014; 60(1):7-16. PubMed ID: 24749244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.